Literature DB >> 28649802

Punctal occlusion for dry eye syndrome.

Ann-Margret Ervin1, Andrew Law, Andrew D Pucker.   

Abstract

BACKGROUND: Dry eye syndrome is a disorder of the tear film that is associated with symptoms of ocular discomfort. Punctal occlusion is a mechanical treatment that blocks the tear drainage system in order to aid in the preservation of natural tears on the ocular surface.
OBJECTIVES: To assess the effects of punctal plugs versus no punctal plugs, different types of punctal plugs, and other interventions for managing dry eye. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2016, Issue 11), MEDLINE Ovid (1946 to 8 December 2016), Embase.com (1947 to 8 December 2016), PubMed (1948 to 8 December 2016), LILACS (Latin American and Caribbean Health Sciences Literature Database) (1982 to 8 December 2016), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com; last searched 18 November 2012 - this resource is now archived), ClinicalTrials.gov (www.clinicaltrials.gov; searched 8 December 2016), and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en; searched 8 December 2016). We did not use any date or language restrictions in the electronic searches for trials. We also searched the Science Citation Index-Expanded database and reference lists of included studies. The evidence was last updated on 8 December 2016 SELECTION CRITERIA: We included randomized and quasi-randomized controlled trials of collagen or silicone punctal plugs in symptomatic participants diagnosed with aqueous tear deficiency or dry eye syndrome. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. We contacted study investigators for additional information when needed. MAIN
RESULTS: We included 18 trials (711 participants, 1249 eyes) from Austria, Canada, China, Greece, Japan, Mexico, Netherlands, Turkey, the UK, and the USA in this review. We also identified one ongoing trial. Overall we judged these trials to be at unclear risk of bias because they were poorly reported. We assessed the evidence for eight comparisons.Five trials compared punctal plugs with no punctal plugs (control). Three of these trials employed a sham treatment and two trials observed the control group. Two trials did not report outcome data relevant to this review. There was very low-certainty evidence on symptomatic improvement. The three trials that reported this outcome used different scales to measure symptoms. In all three trials, there was little or no improvement in symptom scores with punctal plugs compared with no punctal plugs. Low-certainty evidence from one trial suggested less ocular surface staining in the punctal plug group compared with the no punctal plug group however this difference was small and possibly clinically unimportant (mean difference (MD) in fluorescein staining score -1.50 points, 95% CI -1.88 to -1.12; eyes = 61). Similarly there was a small difference in tear film stability with people in the punctal plug group having more stability (MD 1.93 seconds more, 95% CI 0.67 to 3.20; eyes = 28, low-certainty evidence). The number of artificial tear applications was lower in the punctal plug group compared with the no punctal plugs group in one trial (MD -2.70 applications, 95% CI -3.11 to -2.29; eyes = 61, low-certainty evidence). One trial with low-certainty evidence reported little or no difference between the groups in Schirmer scores, but did not report any quantitative data on aqueous tear production. Very low-certainty evidence on adverse events suggested that events occurred reasonably frequently in the punctal plug group and included epiphora, itching, tenderness and swelling of lids with mucous discharge, and plug displacement.One trial compared punctal plugs with cyclosporine (20 eyes) and one trial compared punctal plugs with oral pilocarpine (55 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.Five trials compared punctal plugs with artificial tears. In one of the trials punctal plugs was combined with artificial tears and compared with artificial tears alone. There was very low-certainty evidence on symptomatic improvement. Low-certainty evidence of little or no improvement in ocular surface staining comparing punctal plugs with artificial tears (MD right eye 0.10 points higher, 0.56 lower to 0.76 higher, MD left eye 0.60 points higher, 0.10 to 1.10 higher) and low-certainty evidence of little or no difference in aqueous tear production (MD 0.00 mm/5 min, 0.33 lower to 0.33 higher)Three trials compared punctal plugs in the upper versus the lower puncta, and none of them reported the review outcomes at long-term follow-up. One trial with very low-certainty evidence reported no observed complications, but it was unclear which complications were collected.One trial compared acrylic punctal plugs with silicone punctal plugs and the trial reported outcomes at approximately 11 weeks of follow-up (36 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.One trial compared intracanalicular punctal plugs with silicone punctal plugs at three months follow-up (57 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision.Finally, two trials with very low-certainty evidence compared collagen punctal plugs versus silicone punctal plugs (98 eyes). The evidence was judged to be very low-certainty due to a combination of risk of bias and imprecision. AUTHORS'
CONCLUSIONS: Although the investigators of the individual trials concluded that punctal plugs are an effective means for treating dry eye signs and symptoms, the evidence in this systematic review suggests that improvements in symptoms and commonly tested dry eye signs are inconclusive. Despite the inclusion of 11 additional trials, the findings of this updated review are consistent with the previous review published in 2010. The type of punctal plug investigated, the type and severity of dry eye being treated, and heterogeneity in trial methodology confounds our ability to make decisive statements regarding the effectiveness of punctal plug use. Although punctal plugs are believed to be relatively safe, their use is commonly associated with epiphora and, less commonly, with inflammatory conditions such as dacryocystitis.

Entities:  

Mesh:

Year:  2017        PMID: 28649802      PMCID: PMC5568656          DOI: 10.1002/14651858.CD006775.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  62 in total

1.  Improved functional visual acuity after punctal occlusion in dry eye patients.

Authors:  Eiki Goto; Yukiko Yagi; Minako Kaido; Yukihiro Matsumoto; Kenji Konomi; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

2.  How to identify randomized controlled trials in MEDLINE: ten years on.

Authors:  Julie M Glanville; Carol Lefebvre; Jeremy N V Miles; Janette Camosso-Stefinovic
Journal:  J Med Libr Assoc       Date:  2006-04

3.  The treatment of severe trachomatous dry eye with canalicular silicone plugs.

Authors:  M Guzey; I Ozardali; A Kilic; E Basar; Z Dogan; A Satici; S Karadede
Journal:  Eye (Lond)       Date:  2001-06       Impact factor: 3.775

4.  The clinical efficacy of silicone punctal plug therapy.

Authors:  Ming-Cheng Tai; C Banu Cosar; Elisabeth J Cohen; Christopher J Rapuano; Peter R Laibson
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

5.  Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

Authors:  K Sall; O D Stevenson; T K Mundorf; B L Reis
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

6.  Punctal plugs versus artificial tears for treating dry eye: a comparative observation of their effects on contrast sensitivity.

Authors:  Weiqiang Qiu; Ziyuan Liu; Zhihong Zhang; Mingxin Ao; Xuemin Li; Wei Wang
Journal:  J Ocul Biol Dis Infor       Date:  2012-11-29

7.  Evaluation of a thermosensitive atelocollagen punctal plug treatment for dry eye disease.

Authors:  Takashi Kojima; Yukihiro Matsumoto; Osama M A Ibrahim; Tais Hitomi Wakamatsu; Murat Dogru; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2013-11-06       Impact factor: 5.258

Review 8.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Authors:  A J Lee; J Lee; S-M Saw; G Gazzard; D Koh; D Widjaja; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  The incidence and risk factors for developing dry eye after myopic LASIK.

Authors:  Cintia S De Paiva; Zhuo Chen; Douglas D Koch; M Bowes Hamill; Francis K Manuel; Sohela S Hassan; Kirk R Wilhelmus; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

10.  Effects of lacrimal occlusion with collagen and silicone plugs on patients with conjunctivitis associated with dry eye.

Authors:  Angel Nava-Castaneda; Jose Luis Tovilla-Canales; Lourdes Rodriguez; Jose Luis Tovilla Y Pomar; Clarence E Jones
Journal:  Cornea       Date:  2003-01       Impact factor: 2.651

View more
  12 in total

Review 1.  Topical corticosteroids for dry eye.

Authors:  Su-Hsun Liu; Ian J Saldanha; Alison G Abraham; Thanitsara Rittiphairoj; Scott Hauswirth; Darren Gregory; Cristos Ifantides; Tianjing Li
Journal:  Cochrane Database Syst Rev       Date:  2022-10-21

2.  Acupuncture for dry eye syndrome after refractive surgery: A randomized controlled pilot trial.

Authors:  Jun-Hwan Lee; Kyungsun Han; Tae-Hun Kim; Ae-Ran Kim; Ojin Kwon; Joo-Hee Kim; Jeong-Eun Kim; Seunghoon Lee; Mi-Suk Shin; So-Young Jung; Hyo-Ju Park; Sanghun Lee
Journal:  Integr Med Res       Date:  2020-06-24

3.  Effectiveness of interventions for dry eye: a protocol for an overview of systematic reviews.

Authors:  Paul McCann; Zanna Kruoch; Riaz Qureshi; Tianjing Li
Journal:  BMJ Open       Date:  2022-06-07       Impact factor: 3.006

4.  Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.

Authors:  Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2020-07-30       Impact factor: 5.033

Review 5.  Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products.

Authors:  Victor J Drew; Ching-Li Tseng; Jerard Seghatchian; Thierry Burnouf
Journal:  Front Med (Lausanne)       Date:  2018-02-23

6.  Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease.

Authors:  Claudio Bucolo; Annamaria Fidilio; Claudia Giuseppina Fresta; Francesca Lazzara; Chiara Bianca Maria Platania; Giuseppina Cantarella; Giulia Di Benedetto; Chiara Burgaletto; Renato Bernardini; Cateno Piazza; Stefano Barabino; Filippo Drago
Journal:  Front Pharmacol       Date:  2019-10-18       Impact factor: 5.810

Review 7.  Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome.

Authors:  Pilar Brito-Zerón; Soledad Retamozo; Belchin Kostov; Chiara Baldini; Hendrika Bootsma; Salvatore De Vita; Thomas Dörner; Jacques-Eric Gottenberg; Aike A Kruize; Thomas Mandl; Wan-Fai Ng; Raphaele Seror; Athanasios G Tzioufas; Claudio Vitali; Simon Bowman; Xavier Mariette; Manuel Ramos-Casals
Journal:  RMD Open       Date:  2019-10-28

Review 8.  An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic.

Authors:  Pragnya R Donthineni; Swapna S Shanbhag; Sayan Basu
Journal:  Healthcare (Basel)       Date:  2021-01-17

9.  Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework.

Authors:  Louis Tong; Li Lim; Donald Tan; Wee Jin Heng; Jimmy Lim; Cordelia Chan; Anshu Arundhati; Anna Tan
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-11-11

Review 10.  Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease.

Authors:  Nandini Venkateswaran; Yandong Bian; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2022-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.